Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Engineering chimeric PCSK9 for a vaccine against atherosclerosis
Authors:ID Malenšek, Špela (Author)
ID Lainšček, Duško (Author)
ID Esih, Hana (Author)
ID Orehek, Sara (Author)
ID Fink, Tina (Author)
ID Golob Urbanc, Anja (Author)
ID Blinc, Aleš (Author)
ID Jerala, Roman (Author)
Files:URL URL - Source URL, visit https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(25)00130-5
 
.pdf PDF - Presentation file, download (7,40 MB)
MD5: 0F8C10788AACA651EDEDAF0B73389613
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo KI - National Institute of Chemistry
Publication status:Published
Publication version:Version of Record
Publication date:11.09.2025
Year of publishing:2025
Number of pages:str. 1-16
Numbering:Vol. 33, iss. 3, [article no.] 101535
PID:20.500.12556/DiRROS-23713 New window
UDC:577
ISSN on article:2329-0501
COBISS.SI-ID:250323715 New window
Copyright:© 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.
Note:Nasl. z nasl. zaslona; Opis vira z dne 25. 9. 2025;
Publication date in DiRROS:26.09.2025
Views:279
Downloads:132
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Molecular therapy : Methods & clinical development.
Shortened title:Mol. ther., Methods clin. dev.
Publisher:Nature Publishing Group
ISSN:2329-0501
COBISS.SI-ID:523281177 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0176
Name:Sintezna biologija in imunologija

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4526
Name:Himerna avtologna vakcina proti PCSK9

Funder:EC - European Commission
Funding programme:HE
Project number:101059842
Name:Centre of Excellence for the Technologies of Gene and Cell Therapy
Acronym:CTGCT

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:10.07.2025
Applies to:Text and Data Mining valid from 2025-09-01 Text and Data Mining valid from 2025-09-01 Version of Record valid from 2025-07-10

Secondary language

Language:Slovenian
Keywords:biokemija, srčno-žilne bolezni, ateroskleroza, beljakovine, t-celice, cepiva


Back